Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.

<h4>Background</h4>It is now well recognised that the risk of severe COVID-19 increases with some long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs and there is a lack of data on the influence of multimorbidity (≥2 LTCs) on the risk of COVID-19. Gi...

Full description

Bibliographic Details
Main Authors: Ross McQueenie, Hamish M E Foster, Bhautesh D Jani, Srinivasa Vittal Katikireddi, Naveed Sattar, Jill P Pell, Frederick K Ho, Claire L Niedzwiedz, Claire E Hastie, Jana Anderson, Patrick B Mark, Michael Sullivan, Catherine A O'Donnell, Frances S Mair, Barbara I Nicholl
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0238091

Internet

https://doi.org/10.1371/journal.pone.0238091

Similar Items